Atherectomy Systems Market Set for Robust Growth as Hospitals Adopt Advanced Plaque Removal Devices

 

The global Atherectomy Systems Market is witnessing substantial growth due to the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive treatment procedures worldwide. Atherectomy systems, which are designed to remove plaque buildup from arteries and restore blood flow, are becoming increasingly important in modern vascular treatment practices. According to industry analysis, the market was valued at US$ 621.8 million in 2021 and is projected to exceed US$ 1.1 billion by the end of 2031, expanding at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2022 to 2031.

The rise in peripheral artery disease (PAD), coronary artery disease (CAD), and other cardiovascular conditions has significantly increased the demand for advanced atherectomy technologies. Atherectomy procedures are considered minimally invasive and provide several advantages over traditional open surgeries, including shorter recovery periods, reduced hospital stays, lower complication risks, and improved patient outcomes. As healthcare systems globally continue to emphasize efficient and patient-friendly treatments, atherectomy systems are gaining widespread acceptance among hospitals, specialty clinics, and ambulatory surgical centers.

One of the primary factors driving the growth of the Atherectomy Systems Market is the alarming increase in cardiovascular diseases worldwide. Cardiovascular disorders remain the leading cause of death globally and continue to place a major burden on healthcare systems. Sedentary lifestyles, unhealthy dietary habits, smoking, obesity, hypertension, and rising stress levels are some of the major contributors to the increasing incidence of cardiovascular conditions. In addition, the rapidly aging population is further accelerating the demand for effective vascular treatment solutions.

Healthcare professionals are increasingly adopting atherectomy systems because these devices enable physicians to precisely remove plaque deposits from arteries while preserving healthy vessel structures. The ability to restore proper blood circulation without major surgical intervention has made atherectomy procedures a preferred treatment option for many patients suffering from arterial blockages.

Technological advancements are also playing a critical role in shaping the future of the Atherectomy Systems Market. Manufacturers are heavily investing in research and development activities to introduce innovative devices with enhanced safety, precision, and clinical efficiency. New-generation atherectomy systems are equipped with advanced imaging technologies, improved navigation capabilities, and sophisticated plaque removal mechanisms that help physicians achieve better procedural outcomes.

The growing popularity of minimally invasive procedures is another important factor contributing to market expansion. Patients increasingly prefer treatments that involve smaller incisions, less pain, reduced bleeding, and quicker recovery. Atherectomy procedures align perfectly with these preferences, making them highly attractive in both developed and emerging healthcare markets. Furthermore, minimally invasive procedures are often associated with lower healthcare costs and reduced hospitalization durations, further encouraging their adoption across medical institutions.

Among product types, directional atherectomy devices accounted for a significant share of the global market in 2021. These devices are widely used for the treatment of peripheral artery diseases and are designed to selectively remove plaque from arterial walls. Directional atherectomy systems offer physicians greater control and precision during procedures, making them highly effective in treating complex arterial lesions.

Rotational atherectomy devices are also experiencing increasing adoption due to their ability to treat heavily calcified coronary lesions. These devices use a high-speed rotating burr to grind plaque into microscopic particles that can safely pass through the bloodstream. Orbital atherectomy systems, which utilize orbital motion to modify calcified plaque, are gaining traction for their effectiveness in treating challenging vascular conditions.

Laser atherectomy devices represent another rapidly evolving segment of the market. These systems use laser energy to vaporize plaque and thrombus material within blood vessels. Their ability to treat a wide range of lesion types has contributed to their growing popularity in vascular interventions. Image-guided atherectomy devices are additionally emerging as a promising area of innovation, offering improved visualization and procedural accuracy for physicians.

From an application perspective, cardiovascular diseases remain the largest segment in the Atherectomy Systems Market. However, the use of atherectomy procedures in peripheral artery disease and neurovascular disease treatment is also increasing steadily. The growing awareness regarding the benefits of early vascular intervention and improved diagnosis rates are supporting market growth across these application areas.

Hospitals continue to dominate the end-user segment due to the increasing availability of advanced healthcare infrastructure and specialized cardiovascular treatment facilities. Large hospitals are investing heavily in advanced vascular intervention technologies to improve patient outcomes and expand their treatment capabilities. Specialty clinics and ambulatory surgical centers are also witnessing growing demand for atherectomy systems as outpatient minimally invasive procedures become more common.

Regionally, North America held the largest share of the global Atherectomy Systems Market in 2021, accounting for approximately 30% of the overall industry. The region’s dominance can be attributed to the high prevalence of cardiovascular diseases, strong healthcare infrastructure, favorable reimbursement policies, and the presence of major medical device manufacturers. The United States, in particular, continues to lead the regional market due to increasing research and development activities and rapid adoption of technologically advanced vascular treatment devices.

Europe also represents a significant market for atherectomy systems, supported by rising healthcare expenditure, growing geriatric population, and increasing awareness regarding minimally invasive vascular procedures. Countries such as Germany, the United Kingdom, France, Italy, and Spain are witnessing rising demand for advanced cardiovascular treatment technologies.

Meanwhile, the Asia Pacific region is expected to register the highest CAGR during the forecast period. Rapid urbanization, changing lifestyles, increasing incidence of cardiovascular diseases, and expanding healthcare infrastructure are major factors driving growth in the region. Countries such as China, India, Japan, and Australia are experiencing increasing adoption of advanced medical devices and minimally invasive procedures, creating substantial growth opportunities for market players.

Leading companies operating in the Atherectomy Systems Market are focusing on strategic initiatives such as product launches, partnerships, acquisitions, and geographic expansion to strengthen their market position. Continuous innovation remains a major competitive strategy among industry participants as they seek to address the growing demand for efficient vascular intervention solutions.

Major players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun SE, Cardinal Health Inc., Koninklijke Philips N.V., Becton, Dickinson and Company, RA Medical Systems, and Terumo Corporation. These companies are actively investing in advanced research programs to develop next-generation atherectomy platforms that enhance procedural efficiency and patient safety.

Recent developments in the industry highlight the increasing pace of innovation within the market. In October 2022, Cardiovascular Systems, Inc. launched the 2.00 Max Crown for peripheral orbital atherectomy systems, expanding its Diamondback 360 orbital atherectomy platform. The launch was aimed at improving treatment options for patients with peripheral and coronary artery disease.

Similarly, in August 2022, AngioDynamics, Inc. received 510(k) clearance for an expanded indication for its Auryon Atherectomy System to include arterial thrombectomy. Such regulatory approvals and product innovations are expected to significantly contribute to the future growth of the market.

Despite the positive outlook, certain challenges may hinder market growth to some extent. High procedure costs, stringent regulatory requirements, and the risk of procedural complications may limit adoption in some developing regions. Additionally, the need for skilled healthcare professionals and specialized training for operating advanced atherectomy systems could pose operational challenges for healthcare providers.

Nevertheless, ongoing technological advancements and increasing awareness regarding cardiovascular health are expected to create significant growth opportunities in the coming years. The integration of artificial intelligence, robotics, and advanced imaging technologies into atherectomy procedures may further enhance treatment precision and clinical outcomes.

The future of the Atherectomy Systems Market appears highly promising as healthcare providers continue to prioritize minimally invasive treatment approaches and advanced cardiovascular care solutions. Rising investments in healthcare infrastructure, growing patient awareness, and continuous innovation by leading medical device companies are expected to drive sustained market expansion throughout the forecast period.

As the burden of cardiovascular diseases continues to rise globally, atherectomy systems are likely to play an increasingly important role in vascular intervention procedures. The market is poised for long-term growth, supported by strong demand for safer, faster, and more efficient plaque removal technologies that improve patient quality of life and reduce the risks associated with arterial blockages.